Heart failure & cardiomyopathiesSecondary analysis

Dapagliflozin Enhances Arterial and Venous Compliance During Exercise in Heart Failure With Preserved Ejection Fraction: Insights From the CAMEO-DAPA Trial

CirculationPublished

  • Secondary analysis of the CAMEO-DAPA randomised trial

Authors' conclusion

In patients with HFpEF, treatment with Dapagliflozin improved systemic arterial compliance and venous capacitance during exercise, while reducing aortic characteristic impedance, suggesting a reduction in arterial wall stiffness.

Study context

Population
Patients with heart failure with preserved ejection fraction (HFpEF) undergoing invasive hemodynamic exercise testing with simultaneous echocardiography
Participants
37 patients
Comparison
Dapagliflozin vs placebo
Primary endpoint
Systemic arterial compliance and venous capacitance during exercise
Follow-up
24 weeks

Primary result

As reported in the abstract

Exercise haemodynamics: arterial compliance and venous capacitance
Dapagliflozin vs PlaceboEstimated treatment difference, mm Hg (95% CI)P value
SBP at peak exercise
−18.8(−33.9 to −3.7)
P = 0.016
estimated stressed blood volume, rest and peak exercise
−292(−530 to −53)
P = 0.018
Dapagliflozin vs PlaceboEstimated treatment difference (95% CI)P value
ratio of estimated stressed blood volume to total blood volume (venous capacitance)
−7.3%(−13.3 to −1.3)
P = 0.020
Exertional total arterial compliance improved: ETD 0.06 mL/mm Hg/m² (95% CI 0.003-0.11)
P = 0.039
Aortic root characteristic impedance reduced: ETD −2.6 mm Hg/mL*sec (95% CI −5.1 to −0.03)
P = 0.048

Further findings

Correlations

Reduction in SBP vs change in estimated stressed blood volume during exercise
r=0.40, P=0.019
Decreases in BP vs reduction in pulmonary capillary wedge pressure during exercise
r=0.56, P<0.001

Original publication

Dapagliflozin Enhances Arterial and Venous Compliance During Exercise in Heart Failure With Preserved Ejection Fraction: Insights From the CAMEO-DAPA Trial. Circulation. Published 5 August 2024. doi:10.1161/circulationaha.124.068788

Summarised from the published abstract; every number is checked against it